Patent ID: 9650377
Date: 2017-05-16
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method for the treatment of L-dopa induced dyskinesia in a patient with Parkinson's disease comprising administration of a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof to a patient in need of treatment thereof wherein A is a fused five- to seven-membered monocyclic ring system which may be aromatic, saturated or unsaturated non-aromatic and which may contain from 1 to 4 hetero atoms selected from nitrogen, oxygen and sulfur; R X B each R m is 0, 1, 2, 3 or 4; each R n is 0, 1, 2, 3 or 4; each R R B each R halogen, cyano, hydroxy, amino, C C C C C or a three- to seven-membered monocyclic ring system which may be aromatic, saturated or unsaturated non-aromatic and which may contain from 1 to 4 hetero atoms selected from nitrogen, oxygen and sulfur, wherein the ring system may in turn be substituted once or more than once by R each R or two R each R